![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Chengdu Shengnuo Biopharm Co., Ltd. Chengdu City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Octreotide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-365 - Rev 00
This Chemical Type CEP, issued on October 26, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2414 associated with this CEP further emphasizes